Atossa Therapeutics, Inc. (ATOS) Financials
ATOS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 101.7 million | 3.4 million |
2023-06-30 | 108.4 million | 3.5 million |
2023-03-31 | 116.2 million | 2.9 million |
2022-12-31 | 123.5 million | 5.6 million |
ATOS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -3.9 million | 926000 |
2023-06-30 | -4.5 million | 1.6 million |
2023-03-31 | -7.0 million | 1.6 million |
2022-12-31 | -4.5 million | 1.5 million |
ATOS Net Income
No data available :(
ATOS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 94.0 million | - | - |
2023-06-30 | 99.4 million | - | - |
2023-03-31 | 103.9 million | - | - |
2022-12-31 | 110.9 million | - | - |
ATOS Shares Outstanding
ATOS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 1000 | 4.5 million | 3.0 million | - |
2023-06-30 | 13000 | 3.7 million | 4.1 million | - |
2023-03-31 | - | 3.5 million | 3.6 million | - |
2022-12-31 | 8000 | 5.0 million | 3.2 million | - |
ATOS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 3000 |
2023-06-30 | - | 3000 |
2023-03-31 | - | 3000 |
2022-12-31 | - | 2000 |
ATOS
Price: $1.53
52 week price:
Earnings Per Share: -0.24 USD
P/E Ratio: -3.95
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 530800
Ebitda: -2.0 millionMarket Capitalization: 221.8 million